Biotech Intellectual Property at the Crossroads IP Think Tank Podcast 18 May 2009 (IP Think Tank podcast)

Kelly
Wilton

Office Assistant

Salzburg Cathedral, Austria

Driving through the beautiful streets of Austria in my dishevelled Bedford, I was quite a sight but the sights of Austria were what took my breath away!

photo credit: joiseyshowaa

Global IP Strategy >Pharma, Biotech
& Chem IP Strategy >IP wars >Strategic Management
of IP >See All >

Podcast RSS

05.19.2009 — STRATEGIC MANAGEMENT OF IP, PHARMA, BIOTECH & CHEM IP STRATEGY

Biotech Intellectual Property at the Crossroads IP Think Tank Podcast 18 May 2009

Welcome to this special edition of the IP Think Tank podcast for Monday the 18^th of May 2009. In this call Duncan speaks to Gregory Glover, a panellist at the 2009 BIO International Convention about the pending Biosimilar legislation and concerns over situations where a follow on product might avoid patent claims but still be able to rely on innovator regulatory data.

We hope you enjoy this show, and as always, we look forward to your comments and feedback.

Links:

The 2009 BIO International Convention - http://convention.bio.org

The Panel session 'Biotech Intellectual Property at the Crossroads' - http://convention.bio.org/templates/default_page_template.aspx?id=1415

Gregory Glover - http://www.pharmalawgrp.com/biography.html

download mp3

Biotech Intellectual Property at the Crossroads IP Think Tank Podcast 18 May 2009

0 Comments

Post a Comment